Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Urology|April 3, 2007
Obesity and prostate cancer: a role for adipokinesTina Mistry, Janet E Digby, Ken M Desai, et al.
BJU International|February 19, 2008
Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expressionTina Mistry, Janet E Digby, Ken M Desai, et al.
Bioorganic & Medicinal Chemistry|November 23, 2017
A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumanniiJieun Kwon, Tina Mistry, Jinhong Ren, et al.
BJU International|September 14, 2007
A 10-year retrospective audit of penile cancer management in the UKTina Mistry, Rob W A Jones, Erica Dannatt, et al.
European Radiology|July 18, 2023
Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinomaDavide Prezzi, Keerthini Muthuswamy, Ashik Amlani, et al.
Peptides|October 13, 2009
A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesisSnehal T Patel, Tina Mistry, James E P Brown, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2015
Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI)Shahila Mehboob, Jinhua Song, Kirk E Hevener, et al.
Cell Reports|June 13, 2019
Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-OX40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor ActivityPamela Zhang, Guang Huan Tu, Jie Wei, et al.
Scientific Reports|June 12, 2019
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Scientific Reports|November 9, 2019
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Pageof 2